BNTX
BioNTech SE
NASDAQ · Healthcare · Biotechnology · DE
$89.13
+1.30%Margins
Gross margin
70.8%
EBITDA margin
-35.6%
EBIT margin
-71.8%
Net margin
-64.0%
FCF margin
19.6%
-9.5%
Return on equity
-8.3%
Return on assets
-10.5%
Return on invested capital
0.13x
Asset turnover
$822.0M
Cash from operations
$43
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026